New diabetes clinical trial: A Study of CT-868 in Type 1 Diabetes Mellitus
Published on: October 01, 2023 at 11:00PM
Conditions: Overweight; Obese; Type 1 Diabetes Mellitus
Interventions: Drug: CT-868; Device: CT-868 Pen Injector; Drug: : CT-868 Pen Injector, Placebo
Sponsors: Carmot Therapeutics, Inc.
Not yet recruiting
https://ift.tt/JKSQstw
Conditions: Overweight; Obese; Type 1 Diabetes Mellitus
Interventions: Drug: CT-868; Device: CT-868 Pen Injector; Drug: : CT-868 Pen Injector, Placebo
Sponsors: Carmot Therapeutics, Inc.
Not yet recruiting
https://ift.tt/JKSQstw
Comments
Post a Comment